Exact Mass: 626.5485

Exact Mass Matches: 626.5485

Found 202 metabolites which its exact mass value is equals to given mass value 626.5485, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

DG(16:0/18:1(12Z)-2OH(9,10)/0:0)

(2S)-1-(Hexadecanoyloxy)-3-hydroxypropan-2-yl (9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C37H70O7 (626.5121)

DG(16:0/18:1(12Z)-2OH(9,10)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/18:1(12Z)-2OH(9,10)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(18:1(12Z)-2OH(9,10)/16:0/0:0)

(2S)-2-(Hexadecanoyloxy)-3-hydroxypropyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C37H70O7 (626.5121)

DG(18:1(12Z)-2OH(9,10)/16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-2OH(9,10)/16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(16:0/0:0/18:1(12Z)-2OH(9,10))

(2R)-3-(Hexadecanoyloxy)-2-hydroxypropyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C37H70O7 (626.5121)

DG(16:0/0:0/18:1(12Z)-2OH(9,10)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(18:1(12Z)-2OH(9,10)/0:0/16:0)

(2S)-3-(Hexadecanoyloxy)-2-hydroxypropyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C37H70O7 (626.5121)

DG(18:1(12Z)-2OH(9,10)/0:0/16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/18:1(12Z)-2OH(9,10)/0:0)

(2S)-1-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propan-2-yl (9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C37H70O7 (626.5121)

DG(i-16:0/18:1(12Z)-2OH(9,10)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-16:0/18:1(12Z)-2OH(9,10)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(18:1(12Z)-2OH(9,10)/i-16:0/0:0)

(2S)-3-Hydroxy-2-[(14-methylpentadecanoyl)oxy]propyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C37H70O7 (626.5121)

DG(18:1(12Z)-2OH(9,10)/i-16:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(18:1(12Z)-2OH(9,10)/i-16:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-16:0/0:0/18:1(12Z)-2OH(9,10))

(2R)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C37H70O7 (626.5121)

DG(i-16:0/0:0/18:1(12Z)-2OH(9,10)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(18:1(12Z)-2OH(9,10)/0:0/i-16:0)

(2S)-2-Hydroxy-3-[(14-methylpentadecanoyl)oxy]propyl (9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoic acid

C37H70O7 (626.5121)

DG(18:1(12Z)-2OH(9,10)/0:0/i-16:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Isoprosopilosidine

C40H72N3O2 (626.5624)

2-(Hentriacontane-1-yl)-5,7-dihydroxy-8-methyl-4H-1-benzopyran-4-one

C41H70O4 (626.5274)

((1R,31R)-31-hydroxy-1-methyl-dotriacontyl)-(alpha-L-arabino-3,6-dideoxy-hexopyranoside)|((1R,31R)-31-Hydroxy-1-methyl-dotriacontyl)-(alpha-L-arabino-3,6-didesoxy-hexopyranosid)|O-ascarosyltritriacontane-2,32-diol

((1R,31R)-31-hydroxy-1-methyl-dotriacontyl)-(alpha-L-arabino-3,6-dideoxy-hexopyranoside)|((1R,31R)-31-Hydroxy-1-methyl-dotriacontyl)-(alpha-L-arabino-3,6-didesoxy-hexopyranosid)|O-ascarosyltritriacontane-2,32-diol

C39H78O5 (626.5849)

[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (5E,7Z,9Z,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C44H66O2 (626.5063)

[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoate

C44H66O2 (626.5063)

6-{10-[(2r,5r,6s)-5-hydroxy-6-methylpiperidin-2-yl]decyl}-8-{10-[(2r,5s,6r)-5-hydroxy-6-methylpiperidin-2-yl]decyl}-2,3-dihydro-1h-4λ⁵-indolizin-4-ylium

[C40H72N3O2]+ (626.5624)

8-{10-[(2r,5r,6s)-5-hydroxy-6-methylpiperidin-2-yl]decyl}-6-{10-[(2s,5r,6r)-5-hydroxy-6-methylpiperidin-2-yl]decyl}-2,3-dihydro-1h-4λ⁵-indolizin-4-ylium

[C40H72N3O2]+ (626.5624)

8-{10-[(2r,5r,6s)-5-hydroxy-6-methylpiperidin-2-yl]decyl}-6-{10-[(2s,5r,6r)-5-hydroxy-6-methylpiperidin-2-yl]decyl}-1,2,3,5-tetrahydroindolizin-5-yl

C40H72N3O2 (626.5624)